64 filings
Page 2 of 4
8-K
f5mboc6ybusua0xumps
27 Sep 23
Regulation FD Disclosure
6:58am
8-K
62gwbw4c 7mt
31 Jul 23
Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments
4:29pm
8-K
924tknuaehrlvg g9
28 Jul 23
Biohaven Provides Preliminary EEG Data Update for Kv7 Platform, Regulatory Update on Troriluzole and Other Corporate Updates
4:35pm
8-K
7m2erbn
31 May 23
Biohaven Provides Overview of Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D Day
7:03am
8-K
lgmgl2qilf2sf rvdw7g
12 May 23
Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments
4:47pm
S-8
oon0g7
12 May 23
Registration of securities for employees
4:42pm
8-K
b12ftey9
4 May 23
Departure of Directors or Certain Officers
5:15pm
8-K
k2ewwj8a
23 Mar 23
Investor Presentation March 2023
6:25pm
8-K
k647l
23 Mar 23
Biohaven Reports Fourth Quarter and Full Year 2022 Financial Results and Reports Recent Business Developments
4:35pm
DEFA14A
038k 1mg05aq6syx1
23 Mar 23
Additional proxy soliciting materials
4:30pm
DEF 14A
64sl5y3nckhc1
23 Mar 23
Definitive proxy
4:27pm
10-K
rxw0u6fho qhyi2y8y49
23 Mar 23
Annual report
4:17pm
8-K
1ro slyxjyzh4pay2xe2
10 Jan 23
Regulation FD Disclosure
10:29am
10-Q
sxk9nmrkgbf atq0hj0
9 Nov 22
Quarterly report
4:19pm
8-K
a5ieyt6cnyuo ntgs
9 Nov 22
Biohaven LTD. Reports Third Quarter 2022 Financial Results and Reports Recent Business Developments
4:05pm
424B4
mgy insk9
24 Oct 22
Prospectus supplement with pricing info
9:38am
EFFECT
wbi4s 4a3o8
21 Oct 22
Notice of effectiveness
12:15am
S-1MEF
93x59bku018kk
20 Oct 22
Registration of additional securities for an S-1
9:38pm